Cell therapies against brain tumors: Clinical development and emerging prospects

Area of Science:

• Oncology
• Immunotherapy
• Neuro-oncology

Background:

• Malignant brain tumors, such as glioblastoma multiforme (GBM), are aggressive and have shown minimal treatment efficacy for decades.
• Current standard-of-care treatments offer limited improvement for brain tumor patients.
• Adoptive cell therapies, inspired by CAR-T cell success in other cancers, are being explored for brain tumors.

Purpose of the Study:

• To provide an overview of the clinical landscape of cell therapies for brain tumors.
• To analyze past and active clinical trials involving cell therapies for brain tumors.
• To discuss limitations and emerging approaches for clinical translation of brain tumor cell therapies.

Main Methods:

• Analysis of 203 past and active clinical trials focused on cell therapies for brain tumors.
• Review of preclinical studies investigating enhanced therapeutic cell efficacy for brain tumors.
• Discussion of challenges and emerging strategies in brain tumor cell therapy.

Main Results:

• Clinical trials of GBM-targeting cell therapies, including CAR-T cells, have been initiated but none are approved yet.
• Completed clinical trials have revealed new challenges in the translation of cell therapies for brain tumors.
• Preclinical studies show promise for improving the efficacy of therapeutic cells against brain tumors.

Conclusions:

• Cell therapies, particularly CAR-T cells, represent a hopeful but challenging frontier for treating malignant brain tumors.
• Addressing challenges identified in clinical trials is crucial for advancing brain tumor cell therapy.
• Emerging preclinical strategies offer potential to enhance the effectiveness of cell therapies for brain tumors.